IP Library Patent Application 14247357
Patent Application
App. No. 14/247,357

METHOD FOR SYNTHESIZING PIRFENIDONE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/247,357
Abstract

A process for synthesizing pirfenidone from bromobenzene having less than about 0.15% by weight dibromobenze is disclosed. Also disclosed are processes of synthesizing pirfenidone without using ethyl acetate or n-butanol, and pirfenidone having controlled levels of ethyl acetate, n-butanol, di(5-methyl-2-pyridinone)benzenes, and other impurities having specified retention times. Also disclosed are formulated dosage forms including the disclosed pirfenidone.

Claims (29)

1 . A method of synthesizing pirfenidone comprising

admixing bromobenzene, 5-methyl-2-pyridone, cuprous oxide, and an organic solvent under conditions sufficient to form pirfenidone,

wherein the bromobenzene comprises less than about 0.15% by weight or molar ratio dibromobenzene.

2 . The method of claim 1 , further comprising washing the pirfenidone with a saline solution.

3 . The method of claim 1 , further comprising extracting the pirfenidone from the organic solvent mixture with an extracting organic solvent.

4 . The method of claim 3 , wherein the extracting organic solvent comprises toluene.

5 . The method of claim 1 , further comprising admixing a base with the bromobenzene, 5-methyl-2-pyridone, cuprous oxide, and organic solvent.

6 . The method of claim 5 , wherein the base comprises a carbonate.

7 . The method of claim 6 , wherein the carbonate comprises potassium carbonate.

8 . The method of claim 1 , wherein the organic solvent comprises dimethyl formamide.

9 . The method of claim 1 , further comprising crystallizing the pirfenidone from a solvent mixture comprising heptanes and toluene to form purified pirfenidone.

10 . The method of claim 9 , further comprising recrystallizing the purified pirfenidone by

dissolving at least a portion of the purified pirfenidone in an acidic aqueous solution at an elevated temperature to form a pirfenidone solution;

adding a base to the pirfenidone solution until the pH is at least about 11 to form a basic pirfenidone solution; and

cooling the basic pirfenidone solution to a temperature below about 20° C. to form recrystallized pirfenidone.

11 . The method of claim 9 , comprising performing the crystallizing in the absence of ethyl acetate and in the absence of butanol.

12 . Pirfenidone prepared by a method comprising

admixing bromobenzene, 5-methyl-2-pyridone, cuprous oxide, and an organic solvent under conditions sufficient to form pirfenidone;

wherein the bromobenzene comprises less than about 0.15% by weight or molar ratio dibromobenzene.

13 . The pirfenidone of claim 12 , wherein the method further comprises crystallizing the pirfenidone from a solvent mixture comprising heptanes and toluene to form purified pirfenidone.

14 . The pirfenidone of claim 13 , wherein the method further comprises recrystallizing the purified pirfenidone by

dissolving at least a portion of the purified pirfenidone in an acidic aqueous solution at an elevated temperature to form a pirfenidone solution;

adding a base to the pirfenidone solution until the pH is at least about 11 for form a basic pirfenidone solution; and

cooling the basic pirfenidone solution to a temperature below about 20° C. to form recrystallized pirfenidone,

wherein the recrystallizing is done in the absence of ethyl acetate and in the absence of butanol.

15 . The recrystallized pirfenidone of claim 12 , having a purity of at least 98% by weight or molar ratio and being essentially free of ethyl acetate and essentially free of butanol.

16 . Pirfenidone having less than about 0.1% by weight or molar ratio of a di(5-methyl-2-pyridinone)benzene impurity.

17 . The pirfenidone of claim 16 , having less than about 0.05% by weight or molar ratio of a di(5-methyl-2-pyridone)benzene impurity.

18 . The pirfenidone of claim 16 , having a purity of at least 98% by weight or molar ratio and being essentially free of ethyl acetate and essentially free of butanol.

Assignments (1)
CERTIFICATE OF CHANGE OF COMPANY'S ADDRESS Recorded Jul 27, 2018
From: INTERMUNE, INC.
To: INTERMUNE, INC.
Reel/Frame 046638/0466 →